Q Fever — Research Summary
Printed from RareWays (rareways.com.au) on 12 September 2026
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Seroprevalence of Q-fever among domestic ruminants, humans and ticks in Ethiopia: A systematic review and meta-analysis.
Ambaw Yihenew Getahun et al. — Veterinary and animal science (1 December 2026)
https://pubmed.ncbi.nlm.nih.gov/42436970/
- 2.
Systematic review of
Epelboin Loïc et al. — One health (Amsterdam, Netherlands) (1 December 2026)
https://pubmed.ncbi.nlm.nih.gov/42572555/
- 3.
Topology-encoded multiplex diagnostics enabled by strand composition-controlled amplification.
Lee Eun Yeong et al. — Biosensors & bioelectronics (1 November 2026)
https://pubmed.ncbi.nlm.nih.gov/42287947/
- 4.
Epidemiological investigation of a clinical case of Q fever in the Brazilian Amazon.
Silito Igor Silva et al. — Parasite epidemiology and control (1 November 2026)
https://pubmed.ncbi.nlm.nih.gov/42724665/
- 5.
Global Seroprevalence of Q Fever Antibodies to Coxiella burnetii in Children and Adolescents : A Systematic Review and Meta-analysis.
Teutsch Suzy M et al. — The Pediatric infectious disease journal (1 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42144655/
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Q Fever
Q fever is an infection caused by the bacterium Coxiella burnetii, usually caught by breathing in dust or particles from infected cattle, sheep, goats or other animals. It often causes fever, severe headache, sweats and muscle aches, and some people go on to have long-lasting fatigue or heart valve infection. Antibiotics are the main treatment, and a vaccine is available in Australia for people at higher risk.
Most Recent Research
Q fever is a neglected zoonotic disease that poses a significant threat to the economy, animal health, and public health sectors worldwide, particularly in developing countries such as Ethiopia. In Ethiopia, where livestock production is the primary source of livelihood and food security for many communities, the implications of Q fever are particularly concerning. Despite its importance as a health issue for both animals and humans, there is insufficient national-level consolidated evidence regarding the burden of Q fever in ticks, domestic ruminants, and humans in Ethiopia. Therefore, this meta-analysis aims to assess the pooled prevalence of Q fever among ticks, ruminants, and humans in the country. A systematic review and meta-analysis were conducted in accordance with PRISMA guidelines, using common databases such as Scopus, ScienceDirect, PubMed, Web of Science, and Google Scholar. The literature search was conducted from January 21 to January 30, 2026, to identify articles published in Ethiopia between January 1, 1990, and January 30, 2026. To evaluate the heterogeneity among studies, a random-effects model was employed to explore the pooled prevalence of Q fever in ticks, ruminants, and humans. Subgroup analysis, meta-regression, and sensitivity analysis were conducted to identify sources of variation between studies. Funnel plots, along with Egger's and Begg's correlation tests, were used to assess publication bias. The overall prevalence of Q fever across ticks, ruminants, and humans was 27.0% (95% CI: 20.0-34.0). The pooled prevalence of Q fever was 9% (95% CI: 2.0-16.0) in ticks, 29% (95% CI: 21.0-38.0) in ruminants, and 20% (95% CI: 5.0-36.0) in humans. The prevalence of Q fever was highest in Eastern Ethiopia at 41.0% (95% CI: 22.0-59.0) and lowest in Southwestern Ethiopia at 7.0% (95% CI: 2.0-13.0). Camels exhibited the highest exposure rate at 48.0% (95% CI: 0.0-1.0), while cattle had the lowest at 12.0% (95% CI: 4.0-21.0). The meta-regression analysis revealed that camel and goat species, along with the geographical regions of Eastern and Central Ethiopia, significantly affected the prevalence of Q fever. The findings highlight that Q fever continues to pose a significant threat to ticks, ruminants, and humans in Ethiopia. Therefore, collaboration among environmental, veterinary, and public health professionals is essential for designing and implementing effective prevention and control programs for Q fever in the context of a One Health approach.
Common Questions
What is Q Fever?
Q fever is an infection caused by the bacterium Coxiella burnetii, usually caught by breathing in dust or particles from infected cattle, sheep, goats or other animals. It often causes fever, severe headache, sweats and muscle aches, and some people go on to have long-lasting fatigue or heart valve infection. Antibiotics are the main treatment, and a vaccine is available in Australia for people at higher risk.
How many clinical trials are available for Q Fever?
RareWays currently indexes 7 clinical trials for Q Fever, of which 1 is actively recruiting. Trial availability changes as new studies are registered — check the trials tab for current status.
Where does the research data for Q Fever come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is updated regularly by Rocky, RareWays' automated research engine. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Q Fever.
No spam. Unsubscribe any time. Not medical advice.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.